In biotech’s early days, telling a story to a wide audience used to be part of the path to success. Founders would share a compelling early narrative to potential investors, reporters, and just about anyone else who would listen. Nature papers were the coin of the realm.
Image: http://www.xconomy.com/
To read the original article: Stealth Mode is the New Sweet Spot for Some Biotechs | Xconomy
